TY - JOUR
T1 - Articular Cartilage and Meniscus Predictors of Patient-Reported Outcomes 10 Years After Anterior Cruciate Ligament Reconstruction
T2 - A Multicenter Cohort Study
AU - MOON Knee Group
AU - Brophy, Robert H.
AU - Huston, Laura J.
AU - Briskin, Isaac
AU - Amendola, Annunziato
AU - Cox, Charles L.
AU - Dunn, Warren R.
AU - Flanigan, David C.
AU - Jones, Morgan H.
AU - Kaeding, Christopher C.
AU - Marx, Robert G.
AU - Matava, Matthew J.
AU - McCarty, Eric C.
AU - Parker, Richard D.
AU - Vidal, Armando F.
AU - Wolcott, Michelle L.
AU - Wolf, Brian R.
AU - Wright, Rick W.
AU - Spindler, Kurt P.
N1 - Funding Information:
One or more of the authors has declared the following potential conflict of interest or source of funding: This study was supported in part by grants R01 AR053684 (K.P.S.) and K23AR066133 (M.H.J.) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent official views of the National Institutes of Health. R.H.B. has received consulting fees from ISTO and Sanofi, education support from Elite Orthopedics and Arthrex, and speaking fees from Smith & Nephew and Arthrex. A.A. has received consulting fees from Arthrex and Bioventus, royalties from Arthrex, research support from Stryker, and hospitality payments from Lima USA and SouthTech Orthopedics and holds stock options in Bone Solutions and Rubber City Bracing. W.R.D. has received consulting fees from Linvatec and hospitality payments from Encore Medical and Wright Medical Technology. D.C.F. has received consulting fees from Smith & Nephew, Mitek, Conmed, MTF, Vericel, Zimmer Biomet, Moximed, KCRN, Hyalex, Linvatec, Ceterix, DePuy Synthes, Medical Device Business, DePuy Orthopaedics, and Aastrom Biosciences; fees for services other than consulting from Pacira Pharmaceuticals; and education support from CDC Medical. M.H.J. is on the advisory board for Samumed and receives research support from NIH. C.C.K. has received consulting fees from Zimmer Biomet, fees for services other than consulting from Arthrex and Smith & Nephew, education support from CDC Medical, and a grant from DJO. R.G.M. is on the science advisory board for MEND Nutrition and has received royalties from Springer and Demos Health. M.J.M. has received consulting fees from Arthrex, BREG, Schwartz, Pacira Pharmaceuticals, and Heron Therapeutics and education support from Elite Orthopedics. E.C.M. has received consulting fees from Zimmer Biomet, Biomet Orthopedics, DePuy Orthopedics, and Medical Device Business Services; royalties from Zimmer Biomet and Biomet Sports Medicine; hospitality payments from Arthrex; and education support from Gemini Mountain Medical. R.D.P. has received royalties from Zimmer Biomet and hospitality payments from Smith & Nephew and MTF. A.F.V. has received consulting fees from Stryker and Smith & Nephew and hospitality payments from Arthrex and Steris Corporation. M.L.W. has received education support from Gemini Mountain Medical. B.R.W. has received consulting fees from ConMed Linvatec, royalties from Linvatec, and education support from Smith & Nephew and Arthrex; is on the advisory board for United Health Care; and is a founder/owner of SportsMed Innovate. R.W.W. receives royalties and holds stock in Responsive Arthroscopy. K.P.S. has received consulting fees from Flexion Therapeutics, NovoPedics, and the NFL; has received research support from Smith & Nephew Endoscopy and DJO; and is on the advisory board for NovoPedics. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.
Publisher Copyright:
© 2021 The Author(s).
PY - 2021/9
Y1 - 2021/9
N2 - Background: Articular cartilage and meniscal damage are commonly encountered and often treated at the time of anterior cruciate ligament reconstruction (ACLR). Our understanding of how these injuries and their treatment relate to outcomes of ACLR is still evolving. Hypothesis/Purpose: The purpose of this study was to assess whether articular cartilage and meniscal variables are predictive of 10-year outcomes after ACLR. We hypothesized that articular cartilage lesions and meniscal tears and treatment would be predictors of the International Knee Documentation Committee (IKDC), Knee injury and Osteoarthritis Outcome Score (KOOS) (all 5 subscales), and Marx activity level outcomes at 10-year follow-up after ACLR. Study Design: Cohort study (prognosis); Level of evidence, 1. Methods: Between 2002 and 2008, individuals with ACLR were prospectively enrolled and followed longitudinally using the IKDC, KOOS, and Marx activity score completed at entry, 2, 6, and 10 years. A proportional odds logistic regression model was built incorporating variables from patient characteristics, surgical technique, articular cartilage injuries, and meniscal tears and treatment to determine the predictors (risk factors) of IKDC, KOOS, and Marx outcomes at 10 years. Results: A total of 3273 patients were enrolled (56% male; median age, 23 years at time of enrollment). Ten-year follow-up was obtained on 79% (2575/3273) of the cohort. Incidence of concomitant pathology at the time of surgery consisted of the following: articular cartilage (medial femoral condyle [MFC], 22%; lateral femoral condyle [LFC], 15%; medial tibial plateau [MTP], 4%; lateral tibial plateau [LTP], 11%; patella, 18%; trochlea, 8%) and meniscal pathology (medial, 37%; lateral, 46%). Variables that were predictive of poorer 10-year outcomes included articular cartilage damage in the patellofemoral (P <.01) and medial (P <.05) compartments and previous medial meniscal surgery (7% of knees; P <.04). Compared with no meniscal tear, a meniscal injury was not associated with 10-year outcomes. Medial meniscal repair at the time of ACLR was associated with worse 10-year outcomes for 2 of 5 KOOS subscales, while a medial meniscal repair in knees with grade 2 MFC chondrosis was associated with better outcomes on 2 KOOS subscales. Conclusion: Articular cartilage injury in the patellofemoral and medial compartments at the time of ACLR and a history of medial meniscal surgery before ACLR were associated with poorer 10-year ACLR patient-reported outcomes, but meniscal injury present at the time of ACLR was not. There was limited and conflicting association of medial meniscal repair with these outcomes.
AB - Background: Articular cartilage and meniscal damage are commonly encountered and often treated at the time of anterior cruciate ligament reconstruction (ACLR). Our understanding of how these injuries and their treatment relate to outcomes of ACLR is still evolving. Hypothesis/Purpose: The purpose of this study was to assess whether articular cartilage and meniscal variables are predictive of 10-year outcomes after ACLR. We hypothesized that articular cartilage lesions and meniscal tears and treatment would be predictors of the International Knee Documentation Committee (IKDC), Knee injury and Osteoarthritis Outcome Score (KOOS) (all 5 subscales), and Marx activity level outcomes at 10-year follow-up after ACLR. Study Design: Cohort study (prognosis); Level of evidence, 1. Methods: Between 2002 and 2008, individuals with ACLR were prospectively enrolled and followed longitudinally using the IKDC, KOOS, and Marx activity score completed at entry, 2, 6, and 10 years. A proportional odds logistic regression model was built incorporating variables from patient characteristics, surgical technique, articular cartilage injuries, and meniscal tears and treatment to determine the predictors (risk factors) of IKDC, KOOS, and Marx outcomes at 10 years. Results: A total of 3273 patients were enrolled (56% male; median age, 23 years at time of enrollment). Ten-year follow-up was obtained on 79% (2575/3273) of the cohort. Incidence of concomitant pathology at the time of surgery consisted of the following: articular cartilage (medial femoral condyle [MFC], 22%; lateral femoral condyle [LFC], 15%; medial tibial plateau [MTP], 4%; lateral tibial plateau [LTP], 11%; patella, 18%; trochlea, 8%) and meniscal pathology (medial, 37%; lateral, 46%). Variables that were predictive of poorer 10-year outcomes included articular cartilage damage in the patellofemoral (P <.01) and medial (P <.05) compartments and previous medial meniscal surgery (7% of knees; P <.04). Compared with no meniscal tear, a meniscal injury was not associated with 10-year outcomes. Medial meniscal repair at the time of ACLR was associated with worse 10-year outcomes for 2 of 5 KOOS subscales, while a medial meniscal repair in knees with grade 2 MFC chondrosis was associated with better outcomes on 2 KOOS subscales. Conclusion: Articular cartilage injury in the patellofemoral and medial compartments at the time of ACLR and a history of medial meniscal surgery before ACLR were associated with poorer 10-year ACLR patient-reported outcomes, but meniscal injury present at the time of ACLR was not. There was limited and conflicting association of medial meniscal repair with these outcomes.
KW - ACL reconstruction
KW - IKDC
KW - KOOS
KW - Marx activity
KW - anterior cruciate ligament
KW - chondral injury
KW - meniscal tear
KW - outcomes
UR - http://www.scopus.com/inward/record.url?scp=85111960916&partnerID=8YFLogxK
U2 - 10.1177/03635465211028247
DO - 10.1177/03635465211028247
M3 - Article
C2 - 34324369
AN - SCOPUS:85111960916
SN - 0363-5465
VL - 49
SP - 2878
EP - 2888
JO - American Journal of Sports Medicine
JF - American Journal of Sports Medicine
IS - 11
ER -